Yuki Konishi
Overview
Explore the profile of Yuki Konishi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
615
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ikenouchi A, Fujino Y, Matsumoto T, Okamoto N, Hamada S, Kitagawa S, et al.
J UOEH
. 2025 Mar;
47(1):5-14.
PMID: 40024764
With the increasing incidence of dementia in Japan due to an aging population and declining birthrate, supporting family caregivers is crucial. A survey was conducted at the hospital of the...
2.
Iwamoto K, Nakabayashi T, Yamaguchi A, Konishi Y, Saji M, Yoshimura R, et al.
Neuropsychopharmacol Rep
. 2024 Nov;
44(4):682-687.
PMID: 39497515
Patients with epilepsy often require long-term treatment with antiseizure medications, and their impact on daily activities, particularly driving, is of significant concern. The recently published "Guideline for Evaluating Effects of...
3.
Okamoto N, Sakakibara T, Tsukada N, Chibaatar E, Hayasaki G, Konishi Y, et al.
Psychogeriatrics
. 2024 Sep;
24(6):1425-1427.
PMID: 39284765
No abstract available.
4.
Fujii R, Konishi Y, Furusawa R, Okamoto N, Yoshimura R
PCN Rep
. 2024 Jun;
1(4):e66.
PMID: 38868647
Background: High-dose corticosteroids may be accompanied by central nervous system side-effects, including psychiatric disorders. These psychiatric disorders tend to appear relatively early in treatment. We report an unusual case of...
5.
Nakabayashi T, Iwamoto K, Yamaguchi A, Konishi Y, Saji M, Yoshimura R, et al.
Neuropsychopharmacol Rep
. 2024 Apr;
44(2):308-313.
PMID: 38624143
In December 2022, the Ministry of Health, Labour and Welfare (MHLW) of Japan issued and implemented the guideline for evaluating the effects of psychotropic drugs on motor vehicle driving performance....
6.
Tsukada N, Okamoto N, Konishi Y, Ikenouchi A, Yoshimura R
Cureus
. 2024 Feb;
16(1):e52140.
PMID: 38344569
Marchiafava-Bignami disease is a rare disorder characterized by demyelination and necrosis of the central nervous system. Dystonia is a movement disorder characterized by sustained or intermittent muscle contractions. Herein, we...
7.
Ikenouchi A, Okamoto N, Hamada S, Chibaatar E, Fujii R, Konishi Y, et al.
Brain Behav
. 2023 Oct;
13(12):e3278.
PMID: 37822121
Introduction: Previous studies have suggested association between brain-derived neurotrophic factor (BDNF) and the stress level of workers. However, no studies have investigated the potential of salivary mature BDNF (mBDNF) level...
8.
Hasegawa Y, Konishi Y, Enokido M, Shoji S, Wang M, Fushimi K, et al.
Inorg Chem
. 2023 Sep;
62(41):16794-16800.
PMID: 37733612
Novel hydrophilic and color-changeable single chameleon luminophores composed of Tb(III)/Sm(III) nona-nuclear clusters [TbSm(Sal-PEG-)(μ-OH)](NO) ( = 1, 2, 3, and 9; Sal-PEG-: salicylate polyethylene glycolmethylester, = 2 and 4) are reported...
9.
Konishi Y, Minoshima M, Fujihara K, Uchihashi T, Kikuchi K
Angew Chem Int Ed Engl
. 2023 Aug;
62(40):e202308565.
PMID: 37592736
F magnetic resonance imaging (MRI) is a powerful molecular imaging technique that enables high-resolution imaging of deep tissues without background signal interference. However, the use of nanoparticles (NPs) as F ...
10.
Yanaga M, Okamoto N, Hashimoto R, Igata R, Konishi Y, Ikenouchi A, et al.
J Med Case Rep
. 2023 May;
17(1):221.
PMID: 37246215
Background: Valproic acid (VPA) is a relatively safe drug widely used for the treatment of epileptic seizures and mania in bipolar disorder, as well as the prevention of migraine headaches....